Search

Your search keyword '"Komander D"' showing total 145 results

Search Constraints

Start Over You searched for: Author "Komander D" Remove constraint Author: "Komander D" Language english Remove constraint Language: english
145 results on '"Komander D"'

Search Results

5. Program and abstracts for the 2011 Meeting of the Society for Glycobiology

6. Cezanne regulates E2F1-dependent HIF2 expression

9. Reassessing kinetin's effect on PINK1 and mitophagy.

10. Secondary interactions in ubiquitin-binding domains achieve linkage or substrate specificity.

11. PPTC7 antagonizes mitophagy by promoting BNIP3 and NIX degradation via SCF FBXL4 .

12. Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape.

13. Dominant negative OTULIN-related autoinflammatory syndrome.

15. Interaction of PINK1 with nucleotides and kinetin.

16. Trabid patient mutations impede the axonal trafficking of adenomatous polyposis coli to disrupt neurite growth.

17. Deubiquitinases in cancer.

18. Neutron-encoded diubiquitins to profile linkage selectivity of deubiquitinating enzymes.

19. Characterisation of the OTU domain deubiquitinase complement of Toxoplasma gondii .

20. LUBAC.

21. Inhibitors of SARS-CoV-2 PLpro.

22. Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors.

24. Activation mechanism of PINK1.

25. Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis.

26. USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma.

27. Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains.

29. Correction: The deubiquitylase USP9X controls ribosomal stalling.

30. The deubiquitylase USP9X controls ribosomal stalling.

31. Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities.

32. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.

33. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.

34. Identification and characterization of diverse OTU deubiquitinases in bacteria.

35. Dissecting distinct proteolytic activities of FMDV Lpro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppression.

36. The Tumour Suppressor TMEM127 Is a Nedd4-Family E3 Ligase Adaptor Required by Salmonella SteD to Ubiquitinate and Degrade MHC Class II Molecules.

37. USP30 sets a trigger threshold for PINK1-PARKIN amplification of mitochondrial ubiquitylation.

38. OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer.

39. Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling.

40. Dual role of a GTPase conformational switch for membrane fusion by mitofusin ubiquitylation.

41. Regulation of the endosomal SNX27-retromer by OTULIN.

42. Insights into ubiquitin chain architecture using Ub-clipping.

43. Breaking the chains: deubiquitylating enzyme specificity begets function.

44. Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity.

46. OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death.

47. Evaluating enzyme activities and structures of DUBs.

48. A Chlamydia effector combining deubiquitination and acetylation activities induces Golgi fragmentation.

49. Active site alanine mutations convert deubiquitinases into high-affinity ubiquitin-binding proteins.

50. Mechanism of parkin activation by PINK1.

Catalog

Books, media, physical & digital resources